TAKEDA RESPIRATORY BUSINESS
Takeda defined four therapeutic areas of focus: Gastroenterology, Oncology, Central Nervous System, and Cardiovascular and Metabolic.
TAKEDA RESPIRATORY BUSINESS
Industry:
Therapeutics
Founded:
1781-01-01
Address:
Osaka, Osaka, Japan
Country:
Japan
Status:
Active
More informations about "Takeda Respiratory Business"
Takeda Announces Sale of Respiratory Portfolio to AstraZeneca
Dec 16, 2015 A number of Takeda employees will transfer to AstraZeneca upon completion of the divestiture. The financial impact from this divestiture on Takeda’s 2015 consolidated …See details»
AstraZeneca to strengthen therapy area franchise through …
Dec 16, 2015 AstraZeneca today announced that it has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited (“Takeda”). …See details»
Management Structure | Takeda Pharmaceuticals
Jun 26, 2024 Independent External Directors regularly have meetings consisting only of the Independent External Directors and openly discuss matters relating to Takeda’s business and corporate governance, etc. Independent External …See details»
Takeda Pharmaceutical (Respiratory Business) - PitchBook
Who acquired Takeda Pharmaceutical (Respiratory Business)? Takeda Pharmaceutical (Respiratory Business) was acquired by AstraZeneca. Data Transparency. Meet our data …See details»
Takeda Respiratory Business acquired by AstraZeneca - Crunchbase
Apr 16, 2016 Takeda Respiratory Business Takeda Respiratory Business develops therapeutics. Acquiring Organization: AstraZeneca AstraZeneca is a pharmaceutical company that …See details»
Takeda Pharmaceutical Company - Core Respiratory Business
Takeda Pharmaceutical Company - Core Respiratory Business is a life science company. Life Science M&A Summary in 2015 Out of 60 sectors in the Mergr database, life science ranked 7 …See details»
AstraZeneca to buy Takeda's respiratory business for $575m and …
Dec 16, 2015 In Japan, the company agreed to buy Takeda Pharmaceutical‘s core respiratory business for $575m. Go deeper with GlobalData. Reports. Osteoporosis - China Drug …See details»
Takeda Pharmaceuticals: Global Homepage
Oct 31, 2024 Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.See details»
Takeda - M&A Summary and Business Overview - Mergr
Takeda has acquired 22 companies, including 6 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 6 assets. Takeda’s largest acquisition to date …See details»
AstraZeneca acquires Takeda’s respiratory business
AstraZeneca today announced that it has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited. The deal will include the …See details»
AstraZeneca Acquires Takeda Pharmaceutical Company - Core …
On December 16, 2015, AstraZeneca acquired life science company Takeda Pharmaceutical Company - Core Respiratory Business from Takeda for 575M USD Acquisition Highlights. This …See details»
Takeda to Divest Respiratory Biz to AstraZeneca | PHARMA JAPAN
Takeda Pharmaceutical will sell its respiratory franchise to AstraZeneca for US$575 million in a bid to boost its focus in gastroenterology, oncology, and two other therapeutic areas, …See details»
AstraZeneca completes acquisition of Takeda’s respiratory business
May 3, 2016 AstraZeneca today announced that it has completed the acquisition of the core respiratory business of Takeda Pharmaceutical Company Limited (“Takeda”). The agreement, …See details»
AstraZeneca buys Takeda’s respiratory business - Financial Times
Dec 16, 2015 AstraZeneca. has taken another step to refill its depleted product pipeline by agreeing to pay $575m for the respiratory business of Takeda.. The acquisition gives the UK …See details»
AstraZeneca to Acquire Takeda’s Respiratory Business
Dec 16, 2015 AstraZeneca has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited. The deal will include the …See details»
AstraZeneca acquires Takeda’s respiratory business - Nordic Life …
Dec 15, 2015 AstraZeneca has entered into a definitive agreement to acquire the core respiratory business of Takeda Pharmaceutical Company Limited. The deal will include the …See details»
AstraZeneca Invests in China, To Buy Respiratory Business - Yahoo …
AstraZeneca will also get access to other marketed respiratory medicines and early pipeline products. Moreover, the deal includes the transfer of about 200 of Takeda’s employees to …See details»
AstraZeneca acquires core respiratory business of Takeda ...
Dec 17, 2015 AstraZeneca is increasing its respiratory therapy portfolio with the purchase of Japanese pharmaceutical company Takeda Pharmaceuticals' core respiratory business. …See details»
AstraZeneca boosts respiratory unit with $575 mln Takeda deal
Dec 16, 2015 Britain's AstraZeneca has agreed to buy Takeda Pharmaceutical's respiratory business, including expanded rights to roflumilast, a treatment for chronic obstructive …See details»
Company Facts | Takeda U.S.
Takeda is a patient-focused, innovation-driven global pharmaceutical company that builds on a distinguished 240-year history, aspiring to bring better health and a brighter future for people …See details»